# The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024, Regulation 140: Amendment to Schedule 12A

Extent: E+W+S+N.I.

In Schedule 12A (further provision as to the performance of pharmacovigilance activities)—
(a) in paragraph 1(3), after “UKMA(GB)” insert “or a UKMA(UK)(Category 1)”;
(b) in paragraph 12(5), after “UKMA(GB)” insert “or the UKMA(UK)(Category 1), as the case may be,”;
(c) in paragraph 16(3), after “UKMA(GB)” insert “or the UKMA(UK)(Category 1), as the case may be,”;
(d) in paragraph 22(1)(d), after “UKMA(GB)” insert “or the UKMA(UK)(Category 1)”;
(e) in paragraph 30(g), after “UKMA(GB)” insert “or a UKMA(UK)(Category 1)”.

---
Source: https://www.legislation.gov.uk/uksi/2024/832/regulation/140 (the official version)
Page: https://openlegislation.uk/human-medicines-amendments-relating-to-the-windsor-framework-regulations-2024/regulation-140
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

